Abivax S.A.

AAVXF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$176-$148-$70-$41
Dep. & Amort.$1$1$0$0
Deferred Tax$0$0$1-$1
Stock-Based Comp.$20$8-$1$1
Change in WC$1$21-$10-$1
Other Non-Cash-$1$20$14-$3
Operating Cash Flow-$154-$97-$66-$46
Investing Activities
PP&E Inv.-$1-$0-$4-$2
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$9-$0-$0
Inv. Sales/Matur.$0$1$0$0
Other Inv. Act.$16$1-$0-$0
Investing Cash Flow$16-$8-$4-$1
Financing Activities
Debt Repay.$37$15-$10$19
Stock Issued$0$353$46$70
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$10-$33-$4-$6
Financing Cash Flow$28$335$36$79
Forex Effect$2-$5-$0$0
Net Chg. in Cash-$108$225-$34$31
Supplemental Information
Beg. Cash$252$27$61$29
End Cash$144$252$27$61
Free Cash Flow-$155-$97-$70-$47
Abivax S.A. (AAVXF) Financial Statements & Key Stats | AlphaPilot